Skip to main content

Viskase Holdings, Inc.

VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000727510

No open-market purchases or sales by Viskase Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding VISK, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding VISK at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by Viskase Holdings, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 16, 2023 (view filing)4:05 PM ETJun 14-162 daysRead Randolph CDirectorPPurchase+99.5K$0.1397+$13.9K+99.1%200.0K after2 lots
Aug 17, 2021 (view filing)6:07 PM ETAug 134 daysCouchman Jonathan and 3 others10% OwnerSSaleCommon Stock, $0.01 par value−107.5K$0.3898−$41.9K−5.0%2.04M after2 lots

Top 10 13F holders, Q2 2026

The largest institutional positions in Viskase Holdings, Inc. at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding VISK in 13F filings for Q2 2026.